Literature DB >> 20142766

Brody disease: insights into biochemical features of SERCA1 and identification of a novel mutation.

Gaetano Vattemi1, Francesca Gualandi, Arie Oosterhof, Matteo Marini, Paola Tonin, Paola Rimessi, Marcella Neri, Valeria Guglielmi, Anna Russignan, Consuelo Poli, Toin H van Kuppevelt, Alessandra Ferlini, Giuliano Tomelleri.   

Abstract

Brody disease is an inherited disorder of skeletal muscle function characterized by increasing impairment of relaxation during exercise. The autosomal recessive form can be caused by mutations in the ATP2A1 gene, which encodes for the sarcoplasmic/endoplasmic reticulum Ca-ATPase 1 (SERCA1) protein. We studied 2 siblings affected by Brody disease. The patients complained of exercise-induced delay of muscle relaxation and stiffness since childhood and had gene analysis of ATP2A1. Morphologic and biochemical studies were performed on a muscle biopsy from 1 patient. The biopsy showed fiber size variation and increased numbers of fibers with internal nuclei. Ultrastructural examination revealed dilatation of lateral cisternae and proliferation of tubular elements of the sarcoplasmic reticulum. By immunohistochemistry, SERCA1 was expressed in a normal pattern, but sarcoplasmic reticulum Ca-ATPase activity was significantly reduced. Immunoblotting after high-resolution 2-dimensional gel electrophoresis showed a significant difference in the amount of SERCA1 protein between the patient and controls. Both patients were found to have 2 previously unreported in-frame deletions in ATP2A1. Because SERCA1 protein has specific biochemical characteristics in our patient, these results underline the importance of a pathologic and biochemical analyses for the diagnosis. In addition, we describe 2 novel mutations in the ATP2A1 gene.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142766     DOI: 10.1097/NEN.0b013e3181d0f7d5

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  9 in total

1.  Drug action of benzocaine on the sarcoplasmic reticulum Ca-ATPase from fast-twitch skeletal muscle.

Authors:  D Di Croce; P W Trinks; M B Grifo; D Takara; G A Sánchez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-07-15       Impact factor: 3.000

2.  Rutin stimulates sarcoplasmic reticulum Ca(2+)-ATPase activity (SERCA1) and protects SERCA1 from peroxynitrite mediated injury.

Authors:  Jana Viskupicova; Miriam K Strosova; Petronela Zizkova; Magdalena Majekova; Lubica Horakova
Journal:  Mol Cell Biochem       Date:  2014-12-30       Impact factor: 3.396

3.  Identification of Potential Biomarkers for Ryanodine Receptor 1 (RYR1) Mutation-Associated Myopathies Using Bioinformatics Approach.

Authors:  Xi Wang; Chang Kong; Pan Liu; Wujun Geng; Hongli Tang
Journal:  Dis Markers       Date:  2022-05-23       Impact factor: 3.464

4.  Amide-type local anesthetics action on the sarcoplasmic reticulum Ca-ATPase from fast-twitch skeletal muscle.

Authors:  D E Di Croce; P W Trinks; C de La Cal; G A Sánchez; D Takara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06-20       Impact factor: 3.000

5.  Differential mechanism of the effects of ester-type local anesthetics on sarcoplasmic reticulum Ca-ATPase.

Authors:  G A Sánchez; D E Di Croce; C de la Cal; S B Richard; D Takara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-08-15       Impact factor: 3.000

6.  Mice with RyR1 mutation (Y524S) undergo hypermetabolic response to simvastatin.

Authors:  Mark Knoblauch; Adan Dagnino-Acosta; Susan L Hamilton
Journal:  Skelet Muscle       Date:  2013-09-03       Impact factor: 4.912

7.  Exome analysis identifies Brody myopathy in a family diagnosed with malignant hyperthermia susceptibility.

Authors:  Nyamkhishig Sambuughin; Elena Zvaritch; Natasha Kraeva; Olga Sizova; Erica Sivak; Kelley Dickson; Margaret Weglinski; John Capacchione; Sheila Muldoon; Sheila Riazi; Susan Hamilton; Barbara Brandom; David H MacLennan
Journal:  Mol Genet Genomic Med       Date:  2014-06-06       Impact factor: 2.183

8.  Pseudomyotonia in Romagnola cattle caused by novel ATP2A1 mutations.

Authors:  Leonardo Murgiano; Roberta Sacchetto; Stefania Testoni; Tiziano Dorotea; Francesco Mascarello; Rocco Liguori; Arcangelo Gentile; Cord Drögemüller
Journal:  BMC Vet Res       Date:  2012-10-09       Impact factor: 2.741

9.  Clinical, morphological and genetic characterization of Brody disease: an international study of 40 patients.

Authors:  Joery P Molenaar; Jamie I Verhoeven; Richard J Rodenburg; Erik J Kamsteeg; Corrie E Erasmus; Savine Vicart; Anthony Behin; Guillaume Bassez; Armelle Magot; Yann Péréon; Barbara W Brandom; Valeria Guglielmi; Gaetano Vattemi; Frédéric Chevessier; Jean Mathieu; Jérôme Franques; Karen Suetterlin; Michael G Hanna; Lucie Guyant-Marechal; Marc M Snoeck; Mark E Roberts; Thierry Kuntzer; Roberto Fernandez-Torron; Amaia Martínez-Arroyo; Juergen Seeger; Benno Kusters; Susan Treves; Baziel G van Engelen; Bruno Eymard; Nicol C Voermans; Damien Sternberg
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.